NIH Logo
January 29, 2016
Seen


Israeli Minister of Health, Ambassador Visit

Israeli Minister of Health Yakov Litzman (l) and NIH director Dr. Francis Collins
Israeli Minister of Health Yakov Litzman (l) and NIH director Dr. Francis Collins

Israeli Minister of Health Yakov Litzman and Israeli Ambassador to the U.S. Ron Dermer visited NIH on Jan. 4, following a memorandum of understanding signing with HHS Secretary Sylvia Burwell. The MOU emphasized increased cooperation in the fields of health, medicine and science. While at NIH, Litzman and Dermer and their delegation met with NIH senior leadership, including NIH director Dr. Francis Collins, principal deputy director Dr. Lawrence Tabak, deputy director for intramural research Dr. Michael Gottesman and deputy director for extramural research Dr. Michael Lauer. Later, the group toured the Clinical Research Center and visited a patient unit with Dr. William Gahl, director of the NIH Undiagnosed Diseases Program. Rounding out the afternoon, the group met with NCI leaders, including acting director Dr. Doug Lowy, and attended a Q&A session with Israeli scientists who discussed the importance of NIH, its contribution to health and research in the U.S. and the possibilities of building a similar institution in Israel.

Preparing for a tour of the Clinical Research Center, the Israeli minister of health is greeted by several NIH leaders including (from r) deputy director for extramural research Dr. Michael Lauer, acting deputy director for administration Dr. John McGowan, deputy director for intramural research Dr. Michael Gottesman and FIC director Dr. Roger Glass.
Preparing for a tour of the Clinical Research Center, the Israeli minister of health is greeted by several NIH leaders including (from r) deputy director for extramural research Dr. Michael Lauer, acting deputy director for administration Dr. John McGowan, deputy director for intramural research Dr. Michael Gottesman and FIC director Dr. Roger Glass.

At a Q&A session, NIH scientists (from l) Dr. Ofer Zimmerman of NIAID and Drs. Sigal Shachar and Dr. Jasmin Leshem, both of NCI, talk about the researcher/clinician fellowship that allows physicians to conduct research in the U.S. and see patients related to their research at the same time. “We discussed the significance of this program, how it contributes to advancing and improving medical practice and how we should try and implement a similar program in Israel,” said Shachar.
At a Q&A session, NIH scientists (from l) Dr. Ofer Zimmerman of NIAID and Drs. Sigal Shachar and Dr. Jasmin Leshem, both of NCI, talk about the researcher/clinician fellowship that allows physicians to conduct research in the U.S. and see patients related to their research at the same time. “We discussed the significance of this program, how it contributes to advancing and improving medical practice and how we should try and implement a similar program in Israel,” said Shachar.

Dr. William Gahl (second from l), director of the NIH Undiagnosed Diseases Program, describes a treatment protocol involving the drug EPI-743. Also shown are pediatric nurse practioner Lynne Wolfe (seated) and research nurse Ashley Rice.
Dr. William Gahl (second from l), director of the NIH Undiagnosed Diseases Program, describes a treatment protocol involving the drug EPI-743. Also shown are pediatric nurse practioner Lynne Wolfe (seated) and research nurse Ashley Rice.

NIH leaders gather with the Israeli delegation in the Clinical Research Center’s Medical Board Room.
NIH leaders gather with the Israeli delegation in the Clinical Research Center’s Medical Board Room.

PHOTOS: ERNIE BRANSON
NIH leaders gather with the Israeli delegation in the Clinical Research Center’s Medical Board Room.

 

back to top of page